Title: NEMESIS (NEutrophil MEchanical StabilISation) A novel extracorporeal technology to modulate and monitor pathological inflammatory responses of neutrophils (PMN) in acute respiratory distress syndrome (ARDS).

标题：NEMESIS（中性粒细胞机械稳定）一种新型体外技术，用于调节和监测急性呼吸窘迫综合征（ARDS）中中性粒细胞（PMN）的病理炎症反应。

• 批准号: 364690
• 负责人: Juss Jatinder K
• 金额: $ 0.07万
• 依托单位: Unity Health Toronto
• 依托单位国家: 加拿大
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-01-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=364690&lang=en
• 关键词: Acute Respiratory Distress Syndrome; Critical Illness; Inflammation; Neutrophil; Sepsis

Acute respiratory distress syndrome (ARDS) is a lethal syndrome resulting in intractable respiratory failure. It affects 250, 000 Canadians each year and kills 35, 000; many survivors are left with severe disability and worse long term health outcomes. To

急性呼吸窘迫综合征(ARDS)是一种导致顽固性呼吸衰竭的致命性综合征。它每年影响25000加拿大人，导致35000人死亡；许多幸存者留下严重的残疾和更糟糕的长期健康后果。至